Sky Medical Technology’s Wearable Device Doubles Rate Of Wound Healing

 Sky Medical Technology Ltd, which is part of the Deepbridge Technology Growth EIS portfolio, has recently been featured in an article by Medical Device Network regarding its self-adhesive device, called 'geko', a wearable neuromuscular electro stimulator that delivers a gentle electrical pulse in the leg to stimulate blood flow. The device received U.S Food & Drug Administration (FDA) clearance for improving microcirculatory blood flow in lower limb ischemic tissue in 2021. 

Bernard Ross, CEO of Sky Medical Technology commented: 

“The market that has seen surprisingly little real innovation in SoC over 20 years. Gold standard multi-layer compression can be effective, particularly in less complex and smaller wounds, but even in these patients is too often associated with low patient adherence." 

The study, published in the International Wound Journal, is the first randomised controlled trial to show a statistically significant increase in the rate of healing of venous leg ulcers treated with an advanced neuromuscular electrostimulation device combined with multi-layer compression. 

The most treated wounds in the UK are leg ulcers – chronic wounds that occur in the lower leg. According to the NHS, 1.5% of UK wound patients are estimated to have a leg ulcer. The annual cost of managing wounds in the NHS is £5.3bn and, according to Sky Medical Technology, £2bn of this is spent on venous leg ulcers – the most common type of leg ulcer. 

Click here to find out more. (By following this link you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites).